Skip to main content

Jesus Castro Marrero

Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain.

Institutions of which they are part

Postdoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Jesus Castro Marrero

Institutions of which they are part

Postdoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain.

Jesus Castro earned his Postdoctoral Researcher Fellowship degree in Biochemistry and Molecular Biology program at the Valladolid University School of Medicine, Spain in 1999. Dr. Castro is currently a Senior Postdoctoral Research at the Vall d’Hebron Hospital Research Institute, University of Barcelona School of Medicine, Barcelona, Spain since 2002. In the past 20 years have been devoted to basic research of respiratory medicine, autoimmune and rheumatic conditions with over 50 high-impact factor publications and book chapters. He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain. Dr. Castro is a member of the E.U. CFS/ME Research Collaborative Consortium Initiative (European Myalgic Encephalomyelitis NEtwork-EUROMENE). His current research is focused on the bioenergetic metabolism, mitochondrial dysfunction, and neuroimmune pathways linked to the immune response in CFS/ME, as well as finding useful biomarkers to aid in the diagnosis, treatment, and management of CFS/ME through clinical trials in order to improve prognosis and quality of life of CFS/ME patients.

Projects

Disfunción autonómica y ritmo circadiano en el Síndrome de Fatiga Crónica/Encefalomielitis Miálgica: nuevas herramientas diagnósticas y terapéuticas en la enfermedad

IP: José Alegre Martin
Collaborators: Jesus Castro Marrero
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/00629
Duration: 01/01/2020 - 30/06/2024

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, Silvia Muñoz Caller, Carmen Alonso Cotoner, Ana Maria Gonzalez Castro, Elba Exposito Fernandez, Marc Pigrau Pastor, Xavier Serra Ruiz, Adoración Nieto Ruiz, Alejandro Henao Paez, Consuelo Cammarota, José Alegre Martin, Jesus Castro Marrero, Marta Ribases Haro, Natalia Llonga Tejedor, Amanda Rodríguez Urrutia
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC2019
Duration: 01/01/2020 - 31/12/2024

European Network on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (EUROMENE)

IP: Jesus Castro Marrero
Collaborators: José Alegre Martin
Funding agency: EUROPEAN COMMISSION
Funding: 52000
Reference: EUROMENE_CA15111_COST2015
Duration: 21/04/2016 - 20/04/2020

Fatiga Crónica (GRE)

IP: -
Collaborators: Tomás Fernández de Sevilla Ribosa, Jesus Castro Marrero, Eva Ruiz Ruiz
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 340
Duration: 01/01/2014 - 31/12/2016

Related news

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Related professionals

Caterina  Carbonell Nuñez

Caterina Carbonell Nuñez

Postdoctoral researcher
Read more
Ariadna Gracia Moya

Ariadna Gracia Moya

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Franco Marinello

Franco Marinello

Senior researcher
General Surgery
Read more
Maria Martinez Martinez

Maria Martinez Martinez

Main researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.